IL17A and cerebral malaria: We suggest that IL-22, acting in synergy with IL-17A, may have a deleterious effect in cerebral malaria, through the direct or indirect promotion of BBB permeability and brain inflammation, whilst protecting infected individuals against blood-stage infections and fatal liver tissue damage.